FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely pharmacology, and can be applied in the pathological conditions associated with muscular dystrophy.
EFFECT: invention represents hyaluronidase, applied as an anabolic agent; invention ensures widening the range of medical products applied as anabolics.
4 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INTENSIFICATION OF STEM CELLS MOBILISATION | 2006 |
|
RU2330674C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2007 |
|
RU2336899C1 |
METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 |
|
RU2442601C2 |
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
METHOD FOR PREPARING CELL TRANSPLANTATION MATERIAL IN MYELOSUPPRESSION | 2008 |
|
RU2392947C1 |
EXPERIMENTAL TOXIC CHRONIC HEPATITIS TREATMENT METHOD | 2009 |
|
RU2392000C1 |
AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
HEMOSTIMULANT AND EXCITANT AND METHOD FOR HEMOPOIESIS STIMULATION | 2009 |
|
RU2414926C1 |
METHOD FOR CORRECTING AFFECTED ERYTHROPOIESIS AT EXPERIMENTAL HYPOXIA | 2005 |
|
RU2285300C1 |
TISSUE REGENERATION STIMULATING AGENT | 2013 |
|
RU2599289C2 |
Authors
Dates
2010-01-10—Published
2008-09-23—Filed